View in EDS HTML Full Text PDF Full Text

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.

Saved in:
Bibliographic Details
Title: Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.
Authors: Gerischer, Lea1,2 (AUTHOR), Stascheit, Frauke1,2 (AUTHOR), Mönch, Maximilian3 (AUTHOR), Doksani, Paolo1,2 (AUTHOR), Dusemund, Carla1,2 (AUTHOR), Herdick, Meret1,2 (AUTHOR), Mergenthaler, Philipp1,4,5 (AUTHOR), Stein, Maike1,2 (AUTHOR), Suboh, Amani1,2 (AUTHOR), Schröder‐Braunstein, Jutta6 (AUTHOR), Wabnitz, Guido6 (AUTHOR), Lünemann, Jan D.7 (AUTHOR), Lehnerer, Sophie1,2,8 (AUTHOR), Hoffmann, Sarah1,2 (AUTHOR), Meisel, Andreas1,2,4 (AUTHOR) andreas.meisel@charite.de
Source: Annals of Clinical & Translational Neurology. Apr2026, Vol. 13 Issue 4, p688-699. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23289503
DOI:10.1002/acn3.70251